retatrutide fda approval status october 2025 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation 🎙️ NEW EPISODE: Retatrutide—The Triple
Description
Nordstrand, T
Expertise, Authority, and Trustworthiness In the GLP-1 space, trust is everything

Measuring HRV starts with accurate detection of the exact time between each heartbeat
Lyophilized (freeze-dried) peptide has excellent shelf life when stored properly, typically 12 to 24 months in a cool, dark environment

In the TRIUMPH-1 study, Retatrutide's highest dose resulted in an average weight loss of 28.3% over 80 weeks, compared to 20.9% in trials for tirzepatide

There are two main types of U.S